MODERATE-TO-SEVERE ASTHMA
Clinical trials for MODERATE-TO-SEVERE ASTHMA explained in plain language.
Never miss a new study
Get alerted when new MODERATE-TO-SEVERE ASTHMA trials appear
Sign up with your email to follow new studies for MODERATE-TO-SEVERE ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New asthma pill aims to improve breathing for those not helped by current meds
Disease control Recruiting nowThis study tests an experimental drug called povorcitinib in 240 adults with moderate to severe asthma that is not well controlled by their current inhalers. Participants will receive one of three doses of the drug or a placebo for 24 weeks. The main goal is to see if the drug im…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 02:38 UTC
-
New asthma drug aims to cut severe attacks in half
Disease control Recruiting nowThis study tests a new drug called CM326 for adults with moderate to severe asthma that is not well controlled with current treatments. About 230 participants will receive either CM326 or a placebo for 52 weeks to see if it reduces severe asthma attacks and improves breathing. Th…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New program helps doctors prescribe better asthma treatment
Disease control Recruiting nowThis study works with community health centers to help doctors use a recommended asthma treatment called SMART (Single Maintenance and Reliever Therapy). The program includes training, feedback, and educational tools for both doctors and patients. The goal is to see if this appro…
Matched conditions: MODERATE-TO-SEVERE ASTHMA
Phase: PHASE4 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 12, 2026 13:43 UTC